Brazilian Journal of Aquatic Science and Technology

p. 1-11Souza, C.S.; Barreiro, A. S. & Mafalda Jr., P. 2010. Spatial and temporal patterns of Scaridae larvae (Pisces: Perciformes) in the northeast of Brazil in relation to oceanographic conditions. Braz. J. Aquat. Sci. Technol. 14(2): 1-11. ISSN 1808-7035. This work had as objective to study the distribution and abundance of the Scaridae larvae and to analyze the influence of oceanographic conditions (temperature and salinity), on the space and temporal distribution of larvae. Ichthyoplankton was collected during expeditions: Period 1 (August – October 1995), Period 2 (January – April 1997), Period 3 ( April – July 1998) and Period 4 ( September – December 2000), realized in the Northeast Exclusive Economic Zone. One specie (Cryptotomus roseus) and one genus (Sparisoma sp.) were identified. Sparisoma sp. was the most abundant genus (94% of the total), with higher abundance during all Periods. Cryptotomus roseus was the less abundant specie, representing 6% of the total identified larvae. Cryptotomus roseus presented larger distribution with the maximum density during period 3, between Maceió and Aracajú. Sparisoma sp. larvae were found mainly in oceanic stations and near São Pedro and São Paulo Archipelago

Ichthyoplankton distribution and abundance in the northern Todos os Santos and Camamu Bays, Bahia State - Brazil

The occurrence, distribution and abundance of ichthyoplankton in Todos os Santos and Camamu Bays were analyzed based on four samplings (winter 2003, summer 2003, winter 2004 and summer 2005). Samples were obtained by surface horizontal hauls, using a 200-µm mesh conical-cylinder plankton net. The distribution and abundance of eggs indicate a remarkable seasonal and annual variation of spawning activity in the region, especially when the two summer campaigns are compared. In summer 2003 the highest quantitative values were recorded, especially for Camamu, where the maximum reached 106.56 eggs.m-3, with an overall average of 43.46 eggs.m-3 for the two areas. In summer 2005 values were relatively low, the overall average being 3.49 eggs.m-3. The larval taxonomic composition is characterized by the predominance of gobiids, with small variation from summer to winter. Considering all the campaigns and samplings undertaken in both areas, larvae of 11 families were identified: Engraulidae, Clupeidae, Mugilidae, Atherinopsidae, Hemiramphidae, Syngnathidae, Blenniidae, Carangidae, Gobiidae, Achiridae and Tetraodontidae.<br>O ictioplâncton coletado ao norte da baía de Todos os Santos e na baía de Camamu (Inverno 2003, Verão 2003, Inverno 2004 e Verão 2005) é analisado de forma comparativa. As amostras foram obtidas com redes de plâncton do tipo cônica-cilíndrica de 200 µm de malhagem, em arrastos horizontais de subsuperfície. Os resultados sobre a distribuição e abundância de ovos de peixes sugerem uma ampla variação sazonal e anual da desova. Entre os verões as diferenças foram especialmente visíveis, sendo observados no primeiro verão (dez/03) os maiores valores quantitativos do projeto (máximo = 106,56 ovos.m-3; média = 43,46 ovos.m-3), enquanto que no segundo verão (jan/05) os valores foram em geral baixos (média geral = 3,49 ovos.m-3). A composição taxonômica é caracterizada pela predominância de gobiídeos, com pequenas variações entre o verão e o inverno. Considerando-se todas as campanhas e as duas áreas, foram identificadas larvas de 11 famílias: Engraulidae, Clupeidae, Mugilidae, Atherinopsidae, Hemiramphidae, Syngnathidae, Blenniidae, Carangidae, Gobiidae, Achiridae e Tetraodontidae

Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study

OBJECTIVES: Paediatric cancer is a leading cause of death for children. Children in low-income and middle-income countries (LMICs) were four times more likely to die than children in high-income countries (HICs). This study aimed to test the hypothesis that the COVID-19 pandemic had affected the delivery of healthcare services worldwide, and exacerbated the disparity in paediatric cancer outcomes between LMICs and HICs. DESIGN: A multicentre, international, collaborative cohort study. SETTING: 91 hospitals and cancer centres in 39 countries providing cancer treatment to paediatric patients between March and December 2020. PARTICIPANTS: Patients were included if they were under the age of 18 years, and newly diagnosed with or undergoing active cancer treatment for Acute lymphoblastic leukaemia, non-Hodgkin's lymphoma, Hodgkin lymphoma, Wilms' tumour, sarcoma, retinoblastoma, gliomas, medulloblastomas or neuroblastomas, in keeping with the WHO Global Initiative for Childhood Cancer. MAIN OUTCOME MEASURE: All-cause mortality at 30 days and 90 days. RESULTS: 1660 patients were recruited. 219 children had changes to their treatment due to the pandemic. Patients in LMICs were primarily affected (n=182/219, 83.1%). Relative to patients with paediatric cancer in HICs, patients with paediatric cancer in LMICs had 12.1 (95% CI 2.93 to 50.3) and 7.9 (95% CI 3.2 to 19.7) times the odds of death at 30 days and 90 days, respectively, after presentation during the COVID-19 pandemic (p<0.001). After adjusting for confounders, patients with paediatric cancer in LMICs had 15.6 (95% CI 3.7 to 65.8) times the odds of death at 30 days (p<0.001). CONCLUSIONS: The COVID-19 pandemic has affected paediatric oncology service provision. It has disproportionately affected patients in LMICs, highlighting and compounding existing disparities in healthcare systems globally that need addressing urgently. However, many patients with paediatric cancer continued to receive their normal standard of care. This speaks to the adaptability and resilience of healthcare systems and healthcare workers globally

Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic

Childhood cancer is a leading cause of death. It is unclear whether the COVID-19 pandemic has impacted childhood cancer mortality. In this study, we aimed to establish all-cause mortality rates for childhood cancers during the COVID-19 pandemic and determine the factors associated with mortality